Concepts (181)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prostate | 14 | 2019 | 415 | 3.620 |
Why?
|
| Epithelial Cells | 13 | 2019 | 900 | 2.010 |
Why?
|
| Stem Cells | 9 | 2019 | 712 | 1.630 |
Why?
|
| Prostatic Neoplasms | 8 | 2017 | 1416 | 1.540 |
Why?
|
| PTEN Phosphohydrolase | 9 | 2016 | 254 | 1.410 |
Why?
|
| Receptors, Notch | 4 | 2015 | 204 | 1.140 |
Why?
|
| Prostatic Hyperplasia | 2 | 2016 | 119 | 0.930 |
Why?
|
| Cell Lineage | 6 | 2016 | 348 | 0.860 |
Why?
|
| DEAD-box RNA Helicases | 3 | 2013 | 162 | 0.740 |
Why?
|
| Cell Proliferation | 11 | 2019 | 2464 | 0.730 |
Why?
|
| Cell Differentiation | 10 | 2016 | 1945 | 0.730 |
Why?
|
| Receptors, Androgen | 5 | 2017 | 418 | 0.630 |
Why?
|
| Mice, Inbred C57BL | 11 | 2019 | 4762 | 0.550 |
Why?
|
| Homeostasis | 3 | 2016 | 713 | 0.540 |
Why?
|
| Ribonuclease III | 3 | 2013 | 103 | 0.530 |
Why?
|
| Cell Transformation, Neoplastic | 4 | 2016 | 611 | 0.530 |
Why?
|
| Mice, Transgenic | 8 | 2016 | 2363 | 0.490 |
Why?
|
| Jagged-1 Protein | 1 | 2016 | 53 | 0.490 |
Why?
|
| AC133 Antigen | 1 | 2016 | 35 | 0.490 |
Why?
|
| Androgens | 2 | 2015 | 272 | 0.490 |
Why?
|
| Mice | 21 | 2019 | 18465 | 0.470 |
Why?
|
| Ataxin-1 | 1 | 2015 | 161 | 0.450 |
Why?
|
| Stromal Cells | 4 | 2019 | 314 | 0.440 |
Why?
|
| Animals | 26 | 2019 | 34321 | 0.440 |
Why?
|
| Carcinogenesis | 2 | 2015 | 354 | 0.430 |
Why?
|
| Diet, High-Fat | 1 | 2016 | 263 | 0.420 |
Why?
|
| Neoplasms, Basal Cell | 1 | 2013 | 8 | 0.420 |
Why?
|
| Prostatitis | 1 | 2013 | 21 | 0.410 |
Why?
|
| Keratin-8 | 2 | 2015 | 13 | 0.400 |
Why?
|
| Signal Transduction | 7 | 2016 | 4666 | 0.390 |
Why?
|
| Gene Transfer Techniques | 2 | 2012 | 343 | 0.390 |
Why?
|
| Endoribonucleases | 2 | 2010 | 84 | 0.390 |
Why?
|
| Macrophages | 1 | 2016 | 663 | 0.370 |
Why?
|
| Integrases | 2 | 2015 | 158 | 0.360 |
Why?
|
| Chromosomes, Artificial, Bacterial | 1 | 2012 | 90 | 0.360 |
Why?
|
| Apoptosis | 4 | 2015 | 1861 | 0.340 |
Why?
|
| Transforming Growth Factor beta | 2 | 2019 | 463 | 0.340 |
Why?
|
| rho-Associated Kinases | 1 | 2011 | 47 | 0.330 |
Why?
|
| Amides | 1 | 2011 | 91 | 0.330 |
Why?
|
| Inflammation | 2 | 2016 | 1488 | 0.320 |
Why?
|
| Cell Movement | 1 | 2013 | 875 | 0.310 |
Why?
|
| Pyridines | 1 | 2011 | 260 | 0.300 |
Why?
|
| Male | 21 | 2019 | 65110 | 0.290 |
Why?
|
| Gene Expression Regulation, Neoplastic | 2 | 2015 | 1988 | 0.290 |
Why?
|
| MicroRNAs | 3 | 2011 | 894 | 0.260 |
Why?
|
| Mice, Knockout | 8 | 2017 | 3861 | 0.250 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2011 | 617 | 0.240 |
Why?
|
| Keratin-14 | 2 | 2016 | 10 | 0.230 |
Why?
|
| Gene Expression Regulation | 4 | 2016 | 2354 | 0.220 |
Why?
|
| Microscopy, Fluorescence | 3 | 2016 | 312 | 0.220 |
Why?
|
| Cell Line, Tumor | 6 | 2017 | 3669 | 0.210 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2013 | 1236 | 0.200 |
Why?
|
| Regeneration | 2 | 2016 | 230 | 0.200 |
Why?
|
| Proto-Oncogene Proteins c-akt | 2 | 2014 | 483 | 0.160 |
Why?
|
| Mammary Glands, Animal | 2 | 2015 | 447 | 0.160 |
Why?
|
| Wnt-5a Protein | 1 | 2019 | 23 | 0.150 |
Why?
|
| Disease Progression | 2 | 2015 | 2204 | 0.140 |
Why?
|
| Epithelium | 2 | 2016 | 343 | 0.140 |
Why?
|
| beta Catenin | 2 | 2019 | 209 | 0.130 |
Why?
|
| Antigens, CD | 2 | 2016 | 418 | 0.130 |
Why?
|
| Epithelial-Mesenchymal Transition | 2 | 2016 | 262 | 0.130 |
Why?
|
| TOR Serine-Threonine Kinases | 2 | 2016 | 428 | 0.130 |
Why?
|
| Interleukin-1alpha | 1 | 2016 | 9 | 0.130 |
Why?
|
| Blotting, Western | 3 | 2013 | 1018 | 0.130 |
Why?
|
| GATA Transcription Factors | 1 | 2016 | 7 | 0.130 |
Why?
|
| Mice, SCID | 2 | 2019 | 579 | 0.130 |
Why?
|
| Leukocyte Common Antigens | 1 | 2016 | 84 | 0.120 |
Why?
|
| Chemokine CXCL10 | 1 | 2016 | 52 | 0.120 |
Why?
|
| Ubiquitination | 1 | 2017 | 172 | 0.120 |
Why?
|
| Neutrophil Infiltration | 1 | 2016 | 65 | 0.120 |
Why?
|
| Chemokine CCL2 | 1 | 2016 | 114 | 0.120 |
Why?
|
| Cells, Cultured | 3 | 2019 | 2970 | 0.120 |
Why?
|
| Interleukin-1beta | 1 | 2016 | 159 | 0.120 |
Why?
|
| Myeloid-Derived Suppressor Cells | 1 | 2016 | 52 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-myc | 1 | 2017 | 195 | 0.120 |
Why?
|
| Cell Shape | 1 | 2015 | 70 | 0.120 |
Why?
|
| Biosensing Techniques | 1 | 2016 | 75 | 0.120 |
Why?
|
| Cell Survival | 2 | 2014 | 853 | 0.110 |
Why?
|
| Green Fluorescent Proteins | 2 | 2016 | 382 | 0.110 |
Why?
|
| Plasmids | 1 | 2016 | 455 | 0.110 |
Why?
|
| Anoikis | 1 | 2014 | 8 | 0.110 |
Why?
|
| Tamoxifen | 2 | 2015 | 349 | 0.110 |
Why?
|
| Humans | 14 | 2019 | 131406 | 0.110 |
Why?
|
| In Situ Hybridization, Fluorescence | 1 | 2016 | 755 | 0.110 |
Why?
|
| Cellular Microenvironment | 1 | 2013 | 16 | 0.100 |
Why?
|
| Up-Regulation | 1 | 2016 | 832 | 0.100 |
Why?
|
| Hyperplasia | 1 | 2013 | 183 | 0.100 |
Why?
|
| Transcription Factors | 2 | 2013 | 2436 | 0.100 |
Why?
|
| Immunoenzyme Techniques | 1 | 2013 | 237 | 0.100 |
Why?
|
| Microscopy, Electron, Scanning Transmission | 1 | 2012 | 5 | 0.100 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 2 | 2013 | 1008 | 0.100 |
Why?
|
| Mice, Inbred NOD | 1 | 2013 | 301 | 0.100 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 344 | 0.090 |
Why?
|
| Repressor Proteins | 1 | 2017 | 777 | 0.090 |
Why?
|
| RNA | 1 | 2016 | 531 | 0.090 |
Why?
|
| Organoids | 1 | 2015 | 307 | 0.090 |
Why?
|
| AMP-Activated Protein Kinases | 1 | 2013 | 173 | 0.090 |
Why?
|
| NF-kappa B | 1 | 2014 | 448 | 0.090 |
Why?
|
| Genotyping Techniques | 1 | 2012 | 110 | 0.090 |
Why?
|
| Tumor Cells, Cultured | 1 | 2013 | 989 | 0.090 |
Why?
|
| Cellular Senescence | 1 | 2013 | 221 | 0.090 |
Why?
|
| Colony-Forming Units Assay | 1 | 2011 | 63 | 0.090 |
Why?
|
| Gene Targeting | 1 | 2012 | 170 | 0.090 |
Why?
|
| Real-Time Polymerase Chain Reaction | 1 | 2013 | 530 | 0.090 |
Why?
|
| Genes, Reporter | 1 | 2012 | 350 | 0.080 |
Why?
|
| Spheroids, Cellular | 1 | 2011 | 60 | 0.080 |
Why?
|
| Transgenes | 1 | 2012 | 323 | 0.080 |
Why?
|
| Nuclear Proteins | 1 | 2017 | 1226 | 0.080 |
Why?
|
| Receptor, Notch1 | 1 | 2011 | 75 | 0.080 |
Why?
|
| Enzyme Activation | 1 | 2012 | 588 | 0.080 |
Why?
|
| Clone Cells | 1 | 2011 | 171 | 0.080 |
Why?
|
| Bacterial Infections | 1 | 2013 | 326 | 0.080 |
Why?
|
| Biological Assay | 1 | 2011 | 108 | 0.080 |
Why?
|
| Wnt Proteins | 1 | 2011 | 201 | 0.080 |
Why?
|
| Proto-Oncogene Proteins p21(ras) | 1 | 2011 | 174 | 0.080 |
Why?
|
| Adenocarcinoma | 1 | 2017 | 999 | 0.080 |
Why?
|
| Atrophy | 1 | 2010 | 251 | 0.080 |
Why?
|
| Lentivirus | 1 | 2009 | 81 | 0.080 |
Why?
|
| Cell Separation | 1 | 2010 | 221 | 0.080 |
Why?
|
| Tissue Distribution | 1 | 2010 | 366 | 0.080 |
Why?
|
| Homeodomain Proteins | 1 | 2012 | 568 | 0.080 |
Why?
|
| Organ Size | 1 | 2010 | 434 | 0.070 |
Why?
|
| Multigene Family | 1 | 2010 | 289 | 0.070 |
Why?
|
| Gene Expression Profiling | 2 | 2013 | 1831 | 0.070 |
Why?
|
| Down-Regulation | 1 | 2011 | 659 | 0.070 |
Why?
|
| Immunohistochemistry | 1 | 2012 | 1610 | 0.070 |
Why?
|
| Aging | 1 | 2015 | 1261 | 0.070 |
Why?
|
| Biomarkers, Tumor | 2 | 2013 | 1616 | 0.070 |
Why?
|
| Flow Cytometry | 1 | 2010 | 769 | 0.070 |
Why?
|
| RNA, Messenger | 1 | 2013 | 2567 | 0.070 |
Why?
|
| Genetic Vectors | 1 | 2009 | 901 | 0.060 |
Why?
|
| Disease Models, Animal | 2 | 2013 | 4684 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 2010 | 1397 | 0.060 |
Why?
|
| Female | 6 | 2016 | 71032 | 0.040 |
Why?
|
| Biomarkers | 1 | 2011 | 3400 | 0.040 |
Why?
|
| Receptor Cross-Talk | 1 | 2019 | 36 | 0.040 |
Why?
|
| Stem Cell Niche | 1 | 2019 | 57 | 0.040 |
Why?
|
| Wnt Signaling Pathway | 1 | 2019 | 206 | 0.030 |
Why?
|
| Ubiquitin-Protein Ligase Complexes | 1 | 2017 | 25 | 0.030 |
Why?
|
| Prostatic Intraepithelial Neoplasia | 1 | 2017 | 41 | 0.030 |
Why?
|
| Proteasome Inhibitors | 1 | 2017 | 57 | 0.030 |
Why?
|
| Hepatocyte Nuclear Factor 3-alpha | 1 | 2016 | 43 | 0.030 |
Why?
|
| Zinc Finger E-box-Binding Homeobox 1 | 1 | 2016 | 27 | 0.030 |
Why?
|
| Luminescent Proteins | 1 | 2016 | 157 | 0.030 |
Why?
|
| Granulocyte Colony-Stimulating Factor | 1 | 2016 | 93 | 0.030 |
Why?
|
| Spindle Apparatus | 1 | 2015 | 47 | 0.030 |
Why?
|
| Transforming Growth Factor beta1 | 1 | 2016 | 138 | 0.030 |
Why?
|
| Genetic Engineering | 1 | 2016 | 162 | 0.030 |
Why?
|
| Cadherins | 1 | 2016 | 178 | 0.030 |
Why?
|
| Cell Polarity | 1 | 2015 | 121 | 0.030 |
Why?
|
| Cell Adhesion | 1 | 2015 | 310 | 0.030 |
Why?
|
| Cell Division | 1 | 2015 | 725 | 0.030 |
Why?
|
| Metribolone | 1 | 2013 | 28 | 0.030 |
Why?
|
| Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha | 1 | 2013 | 42 | 0.030 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2013 | 134 | 0.030 |
Why?
|
| Oxidative Phosphorylation | 1 | 2013 | 129 | 0.020 |
Why?
|
| Rats, Wistar | 1 | 2013 | 307 | 0.020 |
Why?
|
| Glycolysis | 1 | 2013 | 171 | 0.020 |
Why?
|
| Promoter Regions, Genetic | 1 | 2016 | 1217 | 0.020 |
Why?
|
| Receptors, Progesterone | 1 | 2015 | 680 | 0.020 |
Why?
|
| RNA Interference | 1 | 2013 | 496 | 0.020 |
Why?
|
| Wnt3 Protein | 1 | 2011 | 4 | 0.020 |
Why?
|
| Tumor Microenvironment | 1 | 2016 | 699 | 0.020 |
Why?
|
| Cell Line, Transformed | 1 | 2011 | 160 | 0.020 |
Why?
|
| Cystadenocarcinoma, Serous | 1 | 2011 | 50 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2013 | 1076 | 0.020 |
Why?
|
| Neoplasms, Glandular and Epithelial | 1 | 2011 | 43 | 0.020 |
Why?
|
| Adult Stem Cells | 1 | 2011 | 55 | 0.020 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2011 | 420 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2011 | 361 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 2011 | 435 | 0.020 |
Why?
|
| Cell Cycle | 1 | 2011 | 598 | 0.020 |
Why?
|
| Ovary | 1 | 2011 | 361 | 0.020 |
Why?
|
| Mitochondria | 1 | 2013 | 759 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2017 | 5119 | 0.020 |
Why?
|
| Trans-Activators | 1 | 2011 | 692 | 0.020 |
Why?
|
| Ovarian Neoplasms | 1 | 2011 | 455 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2011 | 739 | 0.020 |
Why?
|
| Cell Line | 1 | 2011 | 2603 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2016 | 2645 | 0.010 |
Why?
|
| Mutation | 1 | 2017 | 6175 | 0.010 |
Why?
|